Helius Medical Technologies Files 8-K on Security Holder Rights

TL;DR

Helius Medical Technologies filed an 8-K on March 12th, updating security holder rights and financials.

AI Summary

On March 12, 2024, HELIUS MEDICAL TECHNOLOGIES, INC. filed an 8-K report detailing material modifications to the rights of security holders and amendments to its articles of incorporation. The filing also includes financial statements and exhibits, with the report being filed as of March 15, 2024.

Why It Matters

This filing indicates potential changes affecting the rights of Helius Medical Technologies' shareholders and may include important financial disclosures.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate actions and financial statements, not indicating immediate operational or financial distress.

Key Numbers

• 001-38445 — SEC File Number (Identifies the company's filing history with the SEC.)
• 36-4787690 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• HELIUS MEDICAL TECHNOLOGIES, INC. (company) — Registrant
• March 12, 2024 (date) — Date of earliest event reported
• March 15, 2024 (date) — Filing date
• Delaware (jurisdiction) — State of incorporation
• 642 Newtown Yardley Road, Suite 100, Newtown, PA (address) — Business address

FAQ

Key Financial Figures

• $0.001 — hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar

Filing Documents

• hsdt-20240312x8k.htm (8-K) — 50KB
• hsdt-20240312xex3d1.htm (EX-3.1) — 270KB
• hsdt-20240312x8k001.jpg (GRAPHIC) — 7KB
• 0001558370-24-003414.txt ( ) — 505KB
• hsdt-20240312.xsd (EX-101.SCH) — 3KB
• hsdt-20240312_lab.xml (EX-101.LAB) — 16KB
• hsdt-20240312_pre.xml (EX-101.PRE) — 10KB
• hsdt-20240312x8k_htm.xml (XML) — 5KB

03 Material Modification to Rights of Security Holders

Item 3.03 Material Modification to Rights of Security Holders To the extent applicable, the information set forth under Item 5.03 below is incorporated by reference as if fully set forth herein.

03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On March 12, 2024, the Board of Directors (the " Board ") of Helius Medical Technologies, Inc., a Delaware corporation (the " Company ") approved and adopted the Company's Second Amended and Restated Bylaws (the " Second Amended and Restated Bylaws "), which became effective the same day. Among other things, the amendments contained in the Second Amended and Restated Bylaws: Reduce the quorum requirement for all meetings of stockholders of the Company from a majority of the voting power of the outstanding shares of stock entitled to vote to one-third of the voting power of the outstanding shares of stock entitled to vote. Address the universal proxy rules adopted by the U.S. Securities and Exchange Commission, by providing that no person may solicit proxies in support of a director nominee other than the Board's nominees unless such person has, or is part of a group that has, complied with Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the " Exchange Act "), including applicable notice and solicitation requirements. Update disclosure requirements in connection with stockholder nominations of directors and submissions of proposals regarding other business at stockholder meetings (other than proposals to be included in the Company's proxy materials pursuant to Rule 14a-8 under the Exchange Act), including, without limitation, disclosure of derivative security interests and material interests, agreements and relationships between a proposing stockholder (and other participants in a solicitation) and the Company as well as between proposed director nominees and a proposing stockholder and providing that the Board may request a proposing stockholder or proposed director nominee to provide additional information as reasonably required by the Board. Require a stockholder or group of stockholders calling a special meeting in order to nominate a person to the Boar

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 3.1 Second Amended and Restated Bylaws of Helius Medical Technologies, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HELIUS MEDICAL TECHNOLOGIES, INC. Dated: March 15, 2024 By: /s/ Jeffrey S. Mathiesen Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR